Short answer
Danaher Corporation (DHR) filed its Q2 2025 10-Q quarterly report on Jul 22, 2025 for the quarter ended Jun 27, 2025. Quarterly revenue was $5.9B (up 3.4% year over year) with net income of $555M.
Q2 2025 key financials · XBRL
- Revenue
- $5.9B
- +3.4% YoY · +3.4% QoQ
- Net income
- $555M
- −38.8% YoY · −41.8% QoQ
- Operating margin
- 12.8%
- Gross margin
- 59.3%
- EPS (diluted)
- $0.78
- −36.6% YoY · −40.9% QoQ
Source: XBRL data from the Danaher Corporation (DHR) Q2 2025 10-Q on SEC EDGAR. USD.
Danaher Corporation Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Newly added risk: Ongoing U.S.-China tariffs as of July 21, 2025, increasing supply costs and disrupting supply chains
- Most materially updated risk: Tariff-related cost surcharges and price increases affecting product demand and competitive positioning
- Impactful regulatory risk: National laws promoting reshoring and local production, including Chinese policies supporting local medical devices
- Operational risk: Supply chain disruptions from tariffs and trade tensions impacting product availability in key countries
- Financial risk: Margin pressure from inability to fully recover higher tariff-related costs due to delayed or partial cost pass-through
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Danaher Corporation quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.